| Literature DB >> 33919141 |
Justyna Janiszewska1, Joanna Ostrowska1, Dorota Szostak-Węgierek1.
Abstract
The adipose tissue is an active endocrine organ which synthesizes and secretes a variety of adipokines, including adiponectin with its anti-inflammatory properties. Its expression is influenced by numerous factors such as age, sex, body weight and adipose tissue content. However, dietary factors, i.e., diet structure and the percentage of individual nutrients and products, are very important modulators. Beneficial dietary habits are the Mediterranean diet, DASH diet, diet based on plant products and diet with reduced energy value. Moreover, the share of individual products and nutrients which increase the concentration of adiponectin is worth noting. This group may include monounsaturated fatty acids, polyunsaturated omega-3 fatty acids, dietary fiber, polyphenols, alcohol and milk products. Conversely, dietary ingredients which have a negative effect on the concentration of adiponectin are typical components of the Western diet: saturated fatty acids, trans fatty acids, monosaccharides and disaccharides, and red meat. Furthermore, a diet characterized by a high glycemic index such as a high-carbohydrate low-fat diet also seems to be unfavorable. Due to the fact that available knowledge should be systematized, this study aimed to summarize the most recent research on the influence of dietary factors on the concentration of adiponectin.Entities:
Keywords: Mediterranean diet; Western diet; adiponectin; diet; eating pattern; high-molecular-weight adiponectin
Year: 2021 PMID: 33919141 PMCID: PMC8143119 DOI: 10.3390/nu13051394
Source DB: PubMed Journal: Nutrients ISSN: 2072-6643 Impact factor: 5.717
Dietary patterns and the concentration of adiponectin (AD)—A positive effect.
| Author/Reference | Year | Study Design | Sample | Results |
|---|---|---|---|---|
|
| ||||
| Fargnoli et al. [ | 2008 | Prospective cohort study | 1922 women free of CVD, diabetes and cancer, aged 30–55 y | Total AD concentration was 24% higher (15.68 ± 1.03 μg/mL vs. 12.61 ± 1.03 μg/mL; |
| Volp et al. [ | 2016 | Cross-sectional study | 157 apparently healthy men and women, aged 18–35 y | A correlation between the Healthy Eating Index and AD concentrations ( |
|
| ||||
| Mantzoros et al. [ | 2006 | Cross-sectional study | 987 diabetic women, aged 30–55 y | Higher adherence to the MD was associated with markedly higher AD concentrations compared to the lowest adherence (6.91 ± 1.06 μg/mL vs. 5.49 ± 1.04 μg/mL; |
| Fragopoulou et al. [ | 2010 | Cross-sectional study | 532 men and women free of CVD, aged > 18 y | Higher adherence to the MD was associated with markedly higher AD concentrations compared to the lowest adherence (4.8 ± 2.0 μg/mL vs. 3.4 ± 1.9 μg/mL; |
| Schwingshackl et al. [ | 2014 | A systematic review and meta-analysis of 17 interventional studies | 2300 men and women, aged 25–77 y | Adherence to the rules of the MD was related to significantly higher AD concentrations compared to the control diet (WMD: 1.69 mg/mL, 95% CI 0.27, 3.11; |
| Maiorino et al. [ | 2016 | Randomized control study | 215 men and women with newly diagnosed T2DM, aged > 18 y | Following the MD for a year was associated with an increase in total AD concentrations by 43% (6.12 vs. 8.80 μg/mL; |
| Sureda et al. [ | 2018 | Cross-sectional study | 598 men and women, aged 12–65 y | Adherence to the rules of the MD was related to significantly higher AD concentrations compared to non-adherence 13.1 ± 6.7 μg/mL vs. 9.5 ± 2.4 μg/mL; |
| Spadafranca et al. [ | 2018 | Cohort study | 99 normal weight, pregnant women, aged 25–43 y | Women from the highest tertile of adhering to the MD were characterized by a lower decrease in the percentage of AD concentrations compared to women from the lowest tertile (10% ± 11% vs. −34% ± 3%; |
| Luisi et al. [ | 2019 | Interventional study | 36 men and women, aged > 18 y | Following the MD enhanced with 40 g/d of extra virgin olive oil was associated with increased AD concentrations (increase by 0.6 ± 0.26 μg/mL; |
| Kouvari et al. [ | 2020 | Prospective cohort study | 3042 apparently healthy men and women, aged > 18 y | Higher adherence to the MD was associated with markedly higher AD concentrations compared to the lowest adherence 4.8 ± 2.0 μg/mL vs. 3.4 ± 1.9 μg/mL; |
|
| ||||
| Nilsson et al. [ | 2019 | Cross-sectional study | 112 women, aged 65–70 y | The highest tertile of adherence to the DASH diet was associated with markedly higher AD concentrations compared to the lowest tertile (12.9 ± 3.3 μg/mL vs. 11.5 ± 3.4 μg/mL; |
|
| ||||
| Kahleova et al. [ | 2011 | Randomized control study | 74 men and women with T2DM, aged 30–70 y | An increase in total AD by 19% (95% CI 7.5–25.4; |
| Ambroszkiewicz et al. [ | 2018 | Cross-sectional study | 117 prepubertal children, aged 5–10 y | Following a vegetarian diet was associated with a significantly higher adiponectin to leptin ratio (0.70 (0.37–0.93) vs. 0.39 (0.28–0.74); |
| Mirmiran et al. [ | 2019 | Randomized cross-over clinical trial | 31 men and women with T2DM, aged 50–75 y | The consumption of two servings of pulses instead of red meat for eight weeks was associated with an increase in AD concentrations (10.5 ± 3.0 μg/mL vs. 13.1 ± 3.0 μg/mL; |
| 2020 | Case-control study | 76 non-obese men and women, aged 19–59 | Following a vegetarian diet was associated with significantly higher AD concentrations compared to the traditional diet ( | |
|
| ||||
| Christiansen et al. [ | 2010 | Randomized controlled trial | 79 obese men and women, aged 18–45 y | VLCD diet (800 kcal/d) was associated with a 19% increase in AD concentrations after 12 weeks ( |
| Abbenhardt et al. [ | 2013 | Randomized controlled trial | 439 overweight or obese postmenopausal women, aged 50–75 y | AD concentrations increased by 9.5% after 12 months of following LCD (12.4 μg/mL (11.3–13.5) vs. 13.5 μg/mL (12.5–14.6); |
| Bouchonville et al. [ | 2014 | Randomized controlled trial | 107 obese men and women, aged ≥65 y | Calorie reduction of the diet by 500–700 kcal contributed to an increase in AD concentration by 8.9 μg/mL (3.5–14.8); |
| Salehi-Abargouei et al. [ | 2015 | Systematic review and meta-analysis of interventional trials (13 interventional studies) | 937 men and women, aged 20–75 y | The use of LCD was associated with an increase in AD concentration (Hedges’ g = 0.34, 95 % CI 0.17–0.50; |
| 2020 | Interventional study | 20 obese men and women, aged 20–60 y | The use of ketogenic VLCD for 8 weeks was associated with a significant increase in AD concentrations both in women (12.44 ± 1.07 μg/mL vs. 27.3 ± 1.33 μg/mL; | |
|
| ||||
| Fargnoli et al. [ | 2008 | Prospective cohort study | 1922 women, free of CVD, diabetes and cancer, aged 30–55 y | Women from the group characterized by the lowest ratio of PUFA to SFA consumption had significantly higher total AD (12.66 ± 1.03 μg/mL vs. 11.47 ± 1.03 μg/mL; |
| Kalgaonkar et al. [ | 2011 | Randomized, prospective study | 36 women with PCOS, aged 20–45 y | The consumption of walnuts and almonds significantly increased AD concentrations (walnuts: 9.5 ± 1.6 μg/mL vs. 11.3 ± 1.8 μg/mL; |
| Nadjarzadeh et al. [ | 2015 | Randomized double-blind placebo-controlled clinical trial. | 84 women with polycystic ovary syndrome, aged > 18 y | Omega-3 supplementation (180 mg EPA and 120 mg DHA) for eight weeks significantly increased AD concentrations (4.44 ± 1.92 μg/mL vs. 5.62 ± 2.68 μg/mL; |
| Gomes et al. [ | 2015 | Randomized double-blind, placebo-controlled trail | 20 men and women with T2DM, aged 30–65 y | Supplementation with 3 g of ALA increased AD concentrations after 60 days (10.61 ± 6.53 μg/mL vs. 15.01 ± 11.68 μg/mL; |
| Balfegó et al. [ | 2016 | Pilot randomized trial | 35 men and women with T2DM, aged 40–70 y | Introducing 10 g of sardines into the diet (five times a week for six months) was associated with a significant increase in AD concentrations (2.1 ± 0.3 μg/mL vs. 3.0 ± 0.3 μg/mL; |
| Barbosa et al. [ | 2017 | Randomized, double-blind placebo-controlled clinical trial | 80 men and women with at least one cardiovascular risk factor, aged 30–74 y | Omega-3 supplementation (3 g/d) for two months significantly increased AD concentrations (14.8 ± 10.0 μg/mL vs. 18.2 ± 12.1 μg/mL; |
| Mazaherioun et al. [ | 2017 | Randomized, placebo-controlled, double-blind clinical trial | 88 men and women with T2DM, aged 30–65 y | Omega-3 supplementation (2.7 g/d) significantly increased AD concentrations (5.09 ± 2.79 μg/mL vs. 5.58 ± 3.13 μg/mL; |
| Mejia-Montilla et al. [ | 2018 | Prospective study | 195 women with PCOS, aged > 18 y | N-3 supplementation (180 mg EPA and 120 mg DHA) significantly increased AD concentrations (3.9 ± 1.1 μg/mL vs. 5.3 ± 1.4 μg/mL; |
| Song et al. [ | 2018 | Double-blind randomized controlled trial | 201 healthy men and women, aged > 40 y | An increase in AD concentrations over 12 weeks as a result of omega-3 supplementation at a dose of: 3.1 g/d (5.79 ± 2.68 μg/mL vs. 6.36 ± 2.64 μg/mL; |
| Bahreini et al. [ | 2018 | A systematic review and meta-analysis of interventional trials (10 randomized controlled trails) | 177 men and women with T2DM, aged > 18 y | An increase in AD concentrations by 0.57 μg/mL as a result of omega-3 supplementation (95% CI 0.15–1.31; |
| Becic et al. [ | 2018 | A systematic review and meta-analysis of interventional trials (10 randomized controlled trails) | 460 men and women with prediabetes and T2DM, aged > 18 y | An increase in AD concentrations by 0.48 μg/mL as a result of omega-3 supplementation (95% Cl 0.27–0.68; |
| Haidari et al. [ | 2020 | Randomized open-labeled controlled clinical trial | 41 women with PCOS, aged 18–45 y | An increase in AD concentrations over 12 weeks as a result of supplementation with 30 g of ground linseed (13.04 ± 3.36 μg/mL vs. 17.36 ± 4.1 μg/mL; |
| Khorrami et al. [ | 2020 | Randomized double-blind, placebo-controlled study | 80 overweight or obese men and women with atrial fibrillation, aged > 50 y | An increase in AD concentrations over eight weeks as a result of supplementation with 2 g/d of fish oil (11.88 ± 6.94 μg/mL vs. 13.15 ± 7.33 μg/mL; |
| Yang et al. [ | 2020 | A systematic review and meta-analysis of randomized clinical trials (3 randomized controlled trails) | 823 men and women, aged > 18 y | The consumption of walnuts significantly increased AD concentrations (WMD: 0.440 μg/mL; 95% CI: 0.323 to 0.557; |
|
| ||||
| Qi et al. [ | 2005 | Cross-sectional study | 780 men with T2DM, aged 40–75 y | Men from the highest quartile of dietary fiber consumption had significantly higher AD concentrations compared to men from the lowest quartile (17.3 μg/mL vs. 14.2 μg/mL; |
| Mantzoros et al. [ | 2006 | Cross-sectional study | 987 diabetic women, aged 30–55 y | The consumption of whole-grain cereal products was associated with significantly higher AD concentrations (6.11 ± 1.06 μg/mL vs. 4.92 ± 1.05 μg/mL; |
| Fargnoli et al. [ | 2008 | Prospective cohort study | 1922 women free of CVD, diabetes and cancer, aged 30–55 y | Women from the highest quartile of cereal fiber consumption were characterized by significantly higher total AD concentrations (14.73 ± 1.03 μg/mL vs. 13.36 ± 1.04 μg/mL; |
| Pereira et al. [ | 2016 | Observational, cross-sectional study | 43 men and women, 18–60 y | A higher consumption of fiber included in vegetables and fruit was associated with higher AD concentrations (r = 0.50; |
| AlEssa et al. [ | 2016 | Cross-sectional study | 2458 women, free of diabetes, aged 43–70 y | Women from the highest quintile of total fiber ( |
|
| ||||
| Campos-Cervantes et al. [ | 2011 | Randomized, single blind, placebo-controlled trial | 50 obese men, aged 25–30 y | An increase in AD concentrations after six and 12 weeks of supplementation with 500 mg of curcumin (after six weeks: 16.0 μg/mL vs. 18.5 μg/mL; |
| Panahi et al. [ | 2016 | Randomized controlled trial | 117 men and women, aged > 18 y | An increase in AD concentrations after eight weeks of supplementation with 1000 mg of curcumin (12.67 ± 2.13 μg/mL vs. 21.28 ± 4.40 μg/mL; |
| Mirhafez et al. [ | 2019 | Randomized, double blind, placebo-controlled, cross-over trial | 65 men and women with nonalcoholic fatty liver disease, aged > 18 y | Supplementation with 250 mg/d of curcumin for wight weeks caused a significant increase in AD concentrations (14.35 ± 7.72 μg/mL vs. 18.23 ± 9.75 μg/mL; |
| Adibian et al. [ | 2019 | Randomized, double blind, placebo-controlled trial | 44 men and women with T2DM, aged 40–70 y | Supplementation with 1500 mg/d of curcumin for 10 weeks caused a significant increase in AD concentrations (52.0 ± 8.0 μg/mL vs. 64.0 ± 3.0 μg/mL; |
| Clark et al. [ | 2019 | A systematic review and meta-analysis of interventional trials (10 randomized controlled trails) | 652 men and women with type 2 diabetes, prediabetes subjects, obese men or with metabolic syndrome, aged 18–84 y | Supplementation with curcumin caused a significant increase in AD concentrations compared to placebo (WMD: 0.82 Hedges’ g; 95% CI 0.33–1.30; |
| Akbari et al. [ | 2019 | Systematic review and meta-analysis of randomized controlled trials (21 randomized controlled trails) | 1646 men and women with metabolic syndrome | An increase in AD concentrations after supplementation with curcumin (SMD 1.05; 95% CI 0.23–1.87; |
|
| ||||
| Jeong et al. [ | 2014 | Prospective randomized double-blind study | 77 men and women with metabolic syndrome, aged 18–75 y | Daily black raspberry consumption for 12 weeks was associated with an increase in AD concentrations (5.7 ± 5.1 μg/mL vs. 7.7 ± 5.0 μg/mL; |
| Tucakovic et al. [ | 2018 | Randomized, double-blind, placebo-controlled, cross-over trial | 20 apparently healthy men and women, aged 18–65 y | Supplementation with the Queen Garnet plum for four weeks increased AD concentrations by the average of 3.83 μg/mL ( |
| Yang et al. [ | 2020 | Randomized controlled trial | 160 men and women with T2DM or prediabetes | Anthocyanin supplementation for 12 weeks was associated with an increase in AD concentrations compared to placebo (increase by 0.46 μg/mL; |
|
| ||||
| Tomé-Carneiro et al. [ | 2013 | Triple-blind, placebo-controlled clinical trial | 75 men and women, aged > 18 y | Supplementation with grape extract for six months increased AD concentrations by 9.6% ( |
| Mohammadi-Sartang et al. [ | 2017 | Systematic review and meta-analysis of randomized controlled trials (9 randomized controlled trails) | 590 men and women, aged > 18 y | Resveratrol supplementation significantly increased AD concentrations (WMD: 1.10 μg/mL, 95% CI 0.88, 1.33; |
|
| ||||
| Kim et al. [ | 2016 | Randomized double-blind, placebo-controlled study | 37 healthy overweight and obese women | AD increase after 12 weeks of quercetin supplementation (3.6 ± 2.0 μg/mL vs. 6.9 ± 2.3 μg/mL; |
| Rezvan et al. [ | 2018 | Randomized double-blind, placebo-controlled study | 81 women with PCOS, aged 20–40 y | An increased expression of the AD receptors (AdipoR1 and AdipoR2) after 12 weeks of supplementation with 1 g/d of quercetin ( |
|
| ||||
| Shahi et al. [ | 2017 | Randomized double-blind, placebo-controlled study | 48 men and women with T2DM, aged 30–60 y | AD increase after eight weeks of supplementation with 200 mg/d of sesamin (6.21 ± 1.33 μg/mL vs. 7.34 ± 2.88 μg/mL; |
|
| ||||
| Williams et al. [ | 2008 | Prospective cohort study | 982 women with T2DM and 1058 nondiabetic women | The consumption of ≥4 cups of coffee daily was associated with significantly higher AD compared to the consumption of <1 cup a week (women with T2DM: 7.7 vs. 6.1 μg/mL; |
| Kempf et al. [ | 2010 | Single-blind clinical trial | 47 men and women, free of T2DM, aged 18–65 y | The consumption of eight cups of coffee daily was associated with significantly higher AD concentrations compared to consuming no coffee (8421 (6634–11256) ng/mL vs. 7957 (6317, 10901) ng/mL; |
| Imatoh et al. [ | 2011 | Cross-sectional study | 665 men, aged > 18 y | The consumption of ≥3 cups of coffee daily was associated with significantly higher AD compared to consuming no coffee (6.9 ± 3.3 μg/mL vs. 6.0 ± 2.6 μg/mL; |
| Yamashita et al. [ | 2012 | Cross-sectional study | 3317 men and women, aged 35–69 y | The consumption of ≥4 cups of coffee daily was associated with significantly higher AD compared to the consumption of <1 cup a week (7.23 (6.84–7.65) μg/mL vs. 6.58 (6.40–6.76) μg/mL; |
|
| ||||
| Hsu et al. [ | 2008 | Randomized, double-blind, placebo-controlled clinical trial | 78 obese women, aged 16–60 y | An increase in AD concentrations after 12 weeks of supplementation with 400 mg of green tea extract (18.9 ± 6.7 μg/mL vs. 21.4 ± 8.7 μg/mL; |
| Fragopoulou et al. [ | 2010 | Cross-sectional study | 532 men and women free of CVD, aged > 18 y | A correlation was found between green tea consumption and AD concentrations (rho = 0.108; |
| Liu et al. [ | 2014 | Randomized, double-blind, and placebo-controlled trial | 102 men and women with T2DM, aged 20–65 y | An increase in AD concentrations after 16 weeks of supplementation with 500 mg of green tea extract (20.2 ± 5.1 μg/mL vs. 21.7 ± 5.1 μg/mL; |
| Chen et al. [ | 2016 | Randomized, double-blind trial | 92 obese women, aged 20–60 y | An increase in AD concentrations after 12 weeks of supplementation with 856.8 mg of green tea extract (20.9 ± 11.0 μg/mL vs. 24.0 ± 10.7 μg/mL; |
|
| ||||
| Yannakoulia et al. [ | 2008 | Cross-sectional study | 196 apparently healthy women, aged 18–84 y | A correlation occurred between AD and a dietary pattern rich in low-fat dairy and whole-grain cereal products ( |
| Niu et al. [ | 2013 | Cross-sectional one-year longitudinal study | 938 apparently healthy men and women, aged > 18 y | The consumption of low-fat milk products (58.9–375 g/d) was associated with significantly higher AD concentrations compared to no consumption of such products (8.3 (7.8, 8.9) μg/mL vs. 7.3 (6.9, 7.6) μg/mL; |
| Fragopoulou et al. [ | 2010 | Cross-sectional study | 532 man and women free of CVD, aged > 18 y | A correlation occurred between the consumption of low-fat milk products and AD concentrations (rho = 0.119, |
| Bahari et al. [ | 2018 | Cross-sectional study | 612 men and women, 35–69 y | A diet characterized by the higher consumption of milk products was associated with higher AD concentrations (4.78 (3.24, 7.38) μg/mL vs. 3.68 (2.42, 6.12) μg/mL; |
|
| ||||
| Pischon et al. [ | 2005 | Prospective cohort study | 532 men, aged 40–75 y | Men from the highest quintile of AD concentrations (>24.9 μg/mL) consumed significantly more alcohol (16.2 ± 1.06 g/d vs. 13.05 ± 0.7 g/d) compared to men from the lowest quintile of AD concentrations (<10.6 μg/mL); |
| Fargnoli et al. [ | 2008 | Prospective cohort study | 1922 women free of CVD, diabetes and cancer, aged 30–55 y | Total AD concentrations were 28% higher (16.01 ± 1.03 vs. 12.50 ± 1.03; |
| Beulens et al. [ | 2007 | Randomized, controlled, cross-over trial | 17 apparently healthy men, aged 18–40 y |
Moderate alcohol consumption (32 g/d) for four weeks caused an increase in total AD concentrations by 12.5% ( |
| Bell et al. [ | 2015 | Prospective cohort study | 2855 men and women, aged 40–63 y | Alcohol consumption was cross-sectionally associated with AD concentrations (β = 0.003; |
| Nova et al. [ | 2019 | Observational cross-sectional study | 240 men and women, aged 55–85 y | Wine consumption was associated with higher AD ( |
Abbreviations: CVD, Cardiovascular disease; y, years; AHEI, Alternate Healthy Eating Index; AD, adiponectin; AD HMW, high-molecular-weight adiponectin; MD, Mediterranean diet; WMD, Weighted Mean Difference, T2DM, Type 2 Diabetes Mellitus; DASH, Dietary Approach to Stop Hypertension; VLCD, very low calorie diet; LCD, low calorie diet; PUFA, Polyunsaturated Fatty Acids; SFA, Saturated Fatty Acids; PCOS, polycystic ovary syndrome; EPA, eicosapentaenoic acid; DHA, docosahexaenoic acid; ALA, α-linolenic acid; HOMA-IR, Homeostatic Model Assessment of Insulin Resistance.
Dietary patterns and the concentration of adiponectin (AD)—A negative effect.
| Author/Reference | Year | Study Design | Sample | Results |
|---|---|---|---|---|
|
| ||||
| Jafari-Vayghan et al. [ | 2015 | Cross-sectional study | 150 apparently healthy men and women, aged 25–50 y | Adherence to the Western dietary pattern was negatively correlated with AD concentrations ( |
| Alves-Santos et al. [ | 2018 | Prospective cohort study | 173 pregnant women free of infectious and chronic diseases, aged 20–40 y | Adherence to the Western dietary pattern was negatively correlated with AD concentrations during pregnancy (high vs. low tertile of adherence: |
|
| ||||
| Pischon et al. [ | 2005 | Prospective cohort study | 532 men, aged 40–75 y | A 5% increase in energy obtained from carbohydrates instead of lipids was associated with reduction in AD concentrations by 0.59 μg/mL ( |
| Kasim-Karakas et al. [ | 2006 | Interventional study | 22 healthy postmenopausal women, aged > 50 y | Following the eucaloric LFHC diet was linked to a reduction in AD concentrations (16.3 ± 2.1 μg/mL to 14.2 ± 2.0 μg/mL; |
| Rajaie et al. [ | 2013 | Randomized cross-over clinical trial | 30 overweight or obese women with metabol | Following HCD for 6 weeks was linked to AD concentration reduction by 1.68 ± 2.30 μg/mL (10.6 ± 0.3 μg/mL vs. 8.9 ± 0.3 μg/mL; |
| Ruth et al. [ | 2013 | Randomized clinical trial | 55 obese men and women, aged 21–62 y | Following an HFLC diet for 12 weeks was related to a significant increase in AD concentrations (+0.40 ± 0.66 μg/mL, |
| Song et al. [ | 2016 | Randomized controlled interventional study | 93 women and men aged 21–76 years | AD decreased by 9.4% ( |
| Murillo-Ortiz et al. [ | 2017 | Randomized controlled clinical trial | 100 postmenopausal women with breast cancer, aged >48 y | Following a diet with the reduced fat content (12% of energy) for 6 months was associated with reduced AD concentrations (21.23 ± 14.32 μg/mL vs. 16.05 ± 10.25 μg/mL; |
| Meshkini et al. [ | 2018 | Cross-sectional study | 89 apparently healthy men and women, aged 18–75 y | AD concentrations were negatively correlated with the amount of carbohydrates in the diet ( |
|
| ||||
| Qi et al. [ | 2005 | Cross-sectional study | 780 men with T2DM, aged 40–75 y | AD concentrations significantly lower in the highest quintile of the GI of the diet compared to the lowest GI (14.3 μg/mL vs. 16.4 μg/mL; |
| Pischon et al. [ | 2005 | Prospective cohort study | 532 men, aged 40–75 y | Men from the highest quintile of AD concentrations (>24.9 μg/mL) were characterized by a significantly higher GL of the diet (124.7 ± 2.1 vs. 128.5 ± 1.0; |
| Loh et al. [ | 2013 | Cross-sectional study | 305 T2DM men and women, aged 19–75 y | A negative correlation between the GI of the diet and AD concentrations ( |
| Cerman at tal. [ | 2016 | Cross-sectional study | 86 men and women apparently healthy or with acne vulgaris, aged > 18 y | A negative correlation between the GI of the diet and AD concentrations ( |
| Pereira et al. [ | 2016 | Observational, cross-sectional study | 43 men and women, aged 18–60 y | A high GI of the diet was negatively correlated with AD concentrations ( |
| AlEssa et al. [ | 2016 | Cross-sectional study | 2458 women, free of diabetes, aged 43–70 y | Women from the highest quintile of diet GI had significantly lower AD concentrations compared to women from the lowest quintile (11.7 (11.2, 12.3) μg/mL vs. 12.9 (12.4, 13.4) μg/mL; |
| Meshkini et al. [ | 2018 | Cross-sectional study | 89 apparently healthy women and men, aged 18–75 y | AD concentrations were negatively correlated with diet GI ( |
|
| ||||
| Fargnoli et al. [ | 2008 | Prospective cohort study | 1922 women free of CVD, diabetes and cancer, aged 30–55 y | Women from the highest quartile of trans fatty acid consumption had significantly lower total AD concentrations (13.5 ± 1.03 μg/mL vs. 14.96 ± 1.03 μg/mL, |
| Haidari et al. [ | 2014 | Case-control study | 94 men and women apparently healthy or with asthma | AD concentrations were negatively correlated with SFA consumption in persons with asthma ( |
| Pereira et al. [ | 2016 | Observational, cross-sectional study | 43 men and women, aged 18–60 y | AD concentrations were negatively related to the consumption of trans fatty acids ( |
| Prates et al. [ | 2016 | Cross-sectional study | 122 men and women with T1DM, aged > 18 y | AD concentrations were negatively correlated with SFA consumption ( |
| Lepsch et al. [ | 2016 | Prospective cohort study | 201 pregnant women, aged 22–31 y | A negative correlation between SFA consumption and AD concentrations ( |
|
| ||||
| Pollock et al. [ | 2012 | Cross-sectional study | 559 adolescents, aged 14–18 y | A diet with high fructose content was associated with significantly lower AD concentrations (8.4 ± 0.4 μg/mL vs. 9.1 ± 0.4 μg/mL; |
| Rezvani et al. [ | 2013 | Double-blind parallel arm study | 32 overweight or obese men and women, aged 40–72 years | Participants who consumed high quantities of glucose ( |
| Magalhaes et al. [ | 2014 | Cross-sectional study | 60 obese women with nonalcoholic fatty liver disease or apparently healthy, aged >20 y | Diet rich in sucrose was significantly related to low AD concentrations (<0.35 μg/mL) in healthy women ( |
|
| ||||
| Fargnoli et al. [ | 2008 | Prospective cohort study | 1922 women free of CVD, diabetes and cancer, aged 30–55 y | Women from the highest quartile of the red meat to poultry consumption ratio had significantly lower total AD concentrations (13.24 ± 1.03 μg/mL vs. 14.52 ± 1.03 μg/mL, |
| Ley et al. [ | 2014 | Prospective cohort study | 21700 women, aged 30–55 y | Women from the highest quartile of the consumption of red meat (13.7 (13.1, 14.3) μg/mL vs. 15.0 (14.4, 15.6) μg/mL, |
| Chai et al. [ | 2017 | Case-control study | 1223 men and women free of cancer, aged 45–75 y | The consumption of red processed meat was associated with reduced AD concentrations in women ( |
Abbreviations: AD, adiponectin; AD HMW, high-molecular-weight adiponectin; y, years; LFHC, low-fat high-carbohydrate diet, HFLC, high-fat low-carbohydrate diet, HCD, high calorie diet, IG, glycemic index, GL, glycemic load, SFA, Saturated Fatty Acids; CVD, cardiovascular disease, NAFLD, nonalcoholic fatty liver disease.
Figure 1Summary of the influence of dietary factors on the concentration of adiponectin.